The England team has seen some massive changes in approach ever since Brendon McCullum's arrival, but in recent times, they have lost more matches, especially against tough opposition like India and Australia.
Rahul Dravid is regarded as the 'Wall' of Indian cricket. Dravid was given this title following a stellar career where he would tire the bowlers out with his defensive work rate.
"Probably not," Dravid said in an interview with the Telegraph, with a chuckle, when asked whether he would be picked for England under Brendon McCullum and Ben Stokes.
McCullum does not like the term 'Bazball', reveals Rahul Dravid
"It's hard for me to answer that one. I don't know. Sometimes I feel a little bit for McCullum because in my little bit of interaction and conversation with him, I don't think he really likes the term 'Bazball'."
Rahul Dravid mentions 'balance' as a key factor for a Test side
Rahul Dravid reckoned that 'balance' is the key factor for any Test team, and England, despite their aggressive brand of Test cricket, should gel it with some balance, which can see them off to formidable victories.
Rahul Dravid recalled the series between England and India when the English travelled to the eastern part of the world. England had lost that series, but Dravid claimed that the English stars played a fine hand, despite not being able to finish on a promising note.
ALSO READ: Zimbabwe vs Bangladesh all-format series schedule officially announced
Hence then, the article about i won t be picked under brendon mccullum ben stokes rahul dravid s stunning bazball verdict was published today ( ) and is available on cricketaddictor ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( ‘I won’t be picked under Brendon McCullum, Ben Stokes’: Rahul Dravid’s stunning Bazball verdict )
Also on site :
- 2026 ASCO Abstract Highlights: Innovent Biologics' IBI363 (PD-1/IL-2α-bias bispecific fusion protein) Demonstrates Robust Survival Benefits in Long-Term Follow-up of PoC Study in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer
- New ’80s-Inspired Music Movie About a Lost Power Ballad Is Striking a Nostalgic Chord
- Iconic ’90s Rock Band That Helped Define Grunge Tease Major Lineup Change After 27 Years